The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated beta-adrenergic agonist oxidation
- PMID: 15788445
- DOI: 10.1096/fj.04-2868fje
The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated beta-adrenergic agonist oxidation
Abstract
Adipocytes are known to secrete a number of adipokines, but many adipocyte secretions and their functional importance remain to be characterized. This work shows that human white adipocytes and 3T3-F442A-derived adipocytes produce adrenomedullin (AM) and that AM acts in an autocrine/paracrine way on lipid metabolism by extracellular inactivation of isoproterenol, a beta-adrenergic agonist. AM is described as a counter-regulatory factor involved in the control of cardiovascular homeostasis. This peptide is believed to protect the heart from several complications implicated in obesity-linked cardiomorbidity, such as arterial hypertension, cardiac fibrosis, and decreased sinusal variability. The exact source of circulating AM remains a matter of debate, although endothelial and vascular smooth muscle cells seem to be important sites of production. We show that human adipose cells and 3T3-F442A-derived adipocytes express AM receptors and secrete AM. The function of this feature was investigated in 3T3-F442A cell line at the level of lipolysis regulation. AM inhibited beta-adrenergic-stimulated lipolysis by a nitric oxide (NO)-dependent mechanism, inducing a significant decrease in pD2 value for isoproterenol (8.6 +/- 0.2 vs. 9.8 +/- 0.1, P<0.001). This effect is cGMP-independent since it occurred in the presence of the NO-sensitive guanylate cyclase inhibitor ODQ. It is apparently mediated by a novel extracellular mechanism. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) demonstrated that AM-produced NO oxidized isoproterenol to generate its aminochrome, namely isoprenochrome. Isoprenochrome amounts were increased 3.62 +/- 1.13-fold in cell culture media (P<0.05). We describe for the first time that AM down-regulates lipolysis in adipocytes through the chemical modification of a beta-agonist.
Similar articles
-
Nitric oxide inhibits isoproterenol-stimulated adipocyte lipolysis through oxidative inactivation of the beta-agonist.Biochem J. 2000 Oct 15;351 Pt 2(Pt 2):485-93. Biochem J. 2000. PMID: 11023835 Free PMC article.
-
Natriuretic peptides: a new lipolytic pathway in human adipocytes.FASEB J. 2000 Jul;14(10):1345-51. FASEB J. 2000. PMID: 10877827
-
Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism.Metabolism. 2008 Sep;57(9):1307-13. doi: 10.1016/j.metabol.2008.04.028. Metabolism. 2008. PMID: 18702959
-
Adrenomedullin and the control of fluid and electrolyte homeostasis.Annu Rev Physiol. 1999;61:363-89. doi: 10.1146/annurev.physiol.61.1.363. Annu Rev Physiol. 1999. PMID: 10099693 Review.
-
Adrenomedullin in vascular diseases.Curr Hypertens Rep. 2004 Feb;6(1):55-9. doi: 10.1007/s11906-004-0012-x. Curr Hypertens Rep. 2004. PMID: 14972095 Review.
Cited by
-
Efficient in vitro adipocyte model of long-term lipolysis: a tool to study the behavior of lipophilic compounds.In Vitro Cell Dev Biol Anim. 2014 Jun;50(6):507-18. doi: 10.1007/s11626-014-9733-6. Epub 2014 Jan 30. In Vitro Cell Dev Biol Anim. 2014. PMID: 24477563
-
In vitro Lipolysis and Leptin Production of Elephant Seal Blubber Using Precision-Cut Adipose Tissue Slices.Front Physiol. 2020 Dec 10;11:615784. doi: 10.3389/fphys.2020.615784. eCollection 2020. Front Physiol. 2020. PMID: 33362587 Free PMC article.
-
Impact of adrenomedullin blockage on lipid metabolism in female mice exposed to high-fat diet.Endocrine. 2019 Aug;65(2):278-285. doi: 10.1007/s12020-019-01927-8. Epub 2019 Apr 25. Endocrine. 2019. PMID: 31025262 Free PMC article.
-
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells.Cytotherapy. 2013 May;15(5):598-609. doi: 10.1016/j.jcyt.2012.12.008. Epub 2013 Jan 24. Cytotherapy. 2013. PMID: 23352462 Free PMC article. Clinical Trial.
-
Targeted Proteomics Reveals Functional Targets for Early Diabetes Susceptibility in Young Adults.Circ Genom Precis Med. 2024 Feb;17(1):e004192. doi: 10.1161/CIRCGEN.123.004192. Epub 2024 Feb 7. Circ Genom Precis Med. 2024. PMID: 38323454
MeSH terms
Substances
LinkOut - more resources
Full Text Sources